跳到正文
原文
Medical Xpress·· 6 天前AI 评分55

佛罗里达州研究揭示辉瑞新冠疫苗较高的死亡率

Measles elimination at risk—and what a Florida study shows about Pfizer's COVID vaccine

AI 导读

佛罗里达州一项研究发现,辉瑞疫苗的死亡率比莫德纳疫苗高40%,但分析指出该结果可能存在混杂因素,不能直接归因于疫苗。

正文
Measles elimination at risk—and what a Florida study truly shows about Pfizer's COVID vaccine
Of about 11.3 million eligible adults, the researchers matched 981,411 Pfizer recipients to the same number of Moderna recipients on age, sex, race, ethnicity, month of vaccination, type of vaccination site, and census tract, then counted deaths over the next 12 months. Over follow-up, 5,519 deaths from any cause occurred among Moderna recipients and 7,690 in Pfizer recipients, which amounts to a hazard ratio of 1.4, from which the “40% higher death rate” claim comes. Credit: University of Minnesota

A Florida study comparing deaths after the Pfizer and Moderna COVID vaccines is getting a lot of attention, and one statistic from it is filling the echo chambers: a 40% higher rate of death with Pfizer. This edition closes with a closer look at that number and why it doesn't show that the vaccine caused deaths.

First, we'll catch you up on the past two weeks in vaccine policy, including a stalled CDC alert on measles in pregnancy, a missed deadline for childhood vaccine plans and a decision on whether the U.S. keeps its measles elimination status. Then we'll dig into the Florida study to understand what happened and whether this study should change how you think about your COVID vaccine. Let's discuss…

The state of U.S. vaccine policy

The past two weeks brought more measles fallout and more signs of federal vaccine work running behind schedule.

  1. A CDC alert on measles in pregnancy wasn't approved. About a month ago, Centers for Disease Control and Prevention (CDC) scientists tried to warn clinicians about measles in pregnancy through the agency's rapid Health Alert Network, but the CDC director's office did not approve the alert, The Washington Post reports, and the Department of Health and Human Services (HHS), which oversees the CDC, didn't say why. The scientists are now preparing a slower MMWR report or considering a non-CDC journal.
Measles elimination at risk—and what a Florida study truly shows about Pfizer's COVID vaccine
The study only revealed the solid bars above, so it can’t tell these explanations apart. In the diagram, the dashed line indicates what deaths would have been with no vaccine—a quantity that was not measured in the study. Credit: University of Minnesota

Measles during pregnancy can cause serious complications for the mother and baby, including an increased risk of pneumonia, hospitalization and death for the mother, and pregnancy loss, preterm birth, low birth weight and congenital measles for the baby. In Pennsylvania, where the largest U.S. measles outbreak is located, state officials have reported 77 pregnant women diagnosed with measles since April.

  1. HHS misses the deadline for new childhood vaccine plans. HHS officials missed the Nov. 8 deadline that President Donald Trump set for new childhood vaccine plans, though Bloomberg reported on Nov. 6 that HHS had already sent a draft to the White House. An HHS spokesperson said the Task Force on Safer Childhood Vaccines needs time for careful scientific review.

The deadline comes from a White House executive order signed Aug. 10, which gave the task force 90 days to plan for offering childhood vaccines as single products (starting with MMR, which protects against measles, mumps and rubella), reworking the schedule's timeline, finding alternatives to aluminum adjuvants and improving safety monitoring. Separate MMR vaccines are not licensed in the U.S., and Merck has said getting one approved and manufactured could take up to 10 years.

The plans would come on top of HHS's January 2026 overhaul of the childhood schedule, which cut the number of diseases routinely vaccinated against from 17 to 11. A federal judge blocked that overhaul in March, so the earlier schedule (with all 17) remains in effect.

Measles elimination at risk—and what a Florida study truly shows about Pfizer's COVID vaccine
In 2021, the COVID vaccine people received often depended on when and where they were vaccinated. Matching on the type of site, month of vaccination and census tract does balance those factors, but not the specific clinic or exact date. People vaccinated at different clinics or on different dates still may meaningfully differ in underlying health in ways that matching alone cannot fix. Credit: University of Minnesota

As a reminder, the CDC is taking nominations for new ACIP (Advisory Committee on Immunization Practices) members through Dec. 31 (anyone can apply or nominate someone by emailing ACIP@cdc.gov or using the CDC's online form). The call follows a legal fight over the current committee. In June 2025, HHS Secretary Robert F. Kennedy Jr. fired all 17 members of the vaccine advisory committee and replaced them with his own picks.

In March, the same judge blocked 13 of those appointments and every vote the committee had taken, leaving too few members to meet. The government appealed that part of the ruling, and the 1st Circuit heard arguments in October but hasn't ruled. With nominations closing at year's end, a new committee could be in place early in 2027.

  1. A PAHO commission meets this week to decide whether the U.S. keeps its measles elimination status. This week, a Pan American Health Organization (PAHO) commission is meeting Nov. 10 to 13 to decide whether the U.S. can still say it has eliminated measles, a status held since 2000. The commission will decide whether the virus has been spreading in one continuous chain for at least a year, the threshold for losing the status. According to Politico, there have been more than 7,000 cases since January 2025, which makes losing the status likely.

CDC Director Dr. Erica Schwartz said she expects a decision by early next week and that the federal measles response would not change if the status is lost, CNN reports. Writing in the BMJ, Dr. Jennifer Nuzzo notes that Venezuela and Brazil both won their status back after big vaccination initiatives, showing that real investment in public health can undo a status loss.

Measles elimination at risk—and what a Florida study truly shows about Pfizer's COVID vaccine
If a storm causes a tree to fall on a roof, but the repair bill just says "roof damage," a region hit by more storms will look like it also has poorer-quality roofs. Similarly, if a COVID infection was never formally diagnosed but led to a heart attack weeks later, the death certificate may say only "cardiac" as the underlying cause. If one vaccine group had more of these infections, it would look like that group had more non-COVID deaths. The dashed line shows the shortcut in the "claimed vaccine caused harm," which skips over the undiagnosed infection in the middle. Credit: University of Minnesota

A closer look at a claim that Pfizer's COVID vaccine caused hundreds of thousands of excess deaths

A paper published in Global Epidemiology has picked up some traction in the media. In it, researchers conducted a 1:1 matched cohort study among Florida adults who received their first COVID vaccine dose from December 2020 to August 2021. Much of the media has focused on a single statistic that stated adults who received the Pfizer COVID vaccine died at a 40% higher rate over the next 12 months compared with adults who received the Moderna vaccine.

Several of us received the Pfizer vaccine as our first dose, and we'd be lying if we said that statistic didn't jostle us a bit, so we decided to dig into the paper a bit more.

A relative measure (e.g., a hazard ratio of 1.4 or 40% increase) sounds severe and evokes emotion, but fails to acknowledge that the absolute number of deaths in each vaccine group was overall small, and that 99% of the study population remained alive a year later. That nuance is missing in the "40%" claim. A gap of 2,171 deaths (or 221 per 100,000 people over the year) does matter, and we are not dismissing that gap at face value, but drawing the conclusion that these deaths were linked to the COVID vaccine is unfounded, given the observational study design.

Measles elimination at risk—and what a Florida study truly shows about Pfizer's COVID vaccine
The study only measured the first box, and the 221 extra deaths per 100,000 tell us only that the Pfizer group had more deaths than the Moderna group. It doesn’t tell us that the Pfizer vaccine caused them. The extrapolation assumes that if 150 million Americans received the Pfizer vaccine, the same difference seen in Florida would apply to the rest of the U.S., and that all 331,500 deaths were caused by the vaccine. The study never studied the entire U.S., so the last box is a guess. Credit: University of Minnesota

Three reasons to be skeptical of the claim

A matched cohort study pairs each person in one group with a similar person in the other group. That way, if one group has more deaths, the difference is more likely to come from the thing being studied (here, which vaccine people got) than from other factors, like age or where people live. Researchers call these other factors "confounders," because they can muddy the comparison. But matching only makes the groups alike on the factors the researchers match on. The groups can still differ in ways that weren't measured, and those unmeasured differences can still affect the results.

1. Despite matching on demographic and location characteristics, the Pfizer and Moderna groups may differ on health and behaviors.

The authors directly acknowledge that the groups may differ on important factors that could affect the risk of dying, such as other health conditions or behaviors that matching alone cannot account for. We can't tell whether the groups actually do differ, because the study was unable to collect any data on these factors, which is the biggest issue with the analysis as a whole. It's like comparing two used cars of the same make, model and year. If one breaks down more often, you couldn't reasonably blame the model until you knew each car's maintenance history and mileage.

2. The 40% higher death rate could reflect Moderna's vaccine protecting better against COVID, rather than Pfizer's vaccine causing harm.

The authors acknowledge that the Moderna vaccine may have slightly better protection than the Pfizer vaccine against COVID. Two large VA studies found that Moderna vaccine recipients were somewhat less likely than Pfizer vaccine recipients to get infected with or hospitalized due to COVID, though neither paper found a difference in COVID deaths.

Better protection against COVID could also affect the deaths that were not due to COVID. Acute COVID can trigger heart attacks, strokes and other health problems weeks later, but a death certificate may list only a heart attack as the underlying cause. That would change how a death is labeled and classified in the study, but not how many of the people died. If this mislabeling happened more often in the Pfizer vaccine recipients, some of the extra 'non-COVID' deaths observed, which make up about 87% of the extra deaths reported in the paper, could potentially trace back to COVID itself.

The authors reran the analysis in people without a documented COVID diagnosis before vaccination, and in 2021, many infections were not lab-confirmed or recorded, so while better COVID protection may explain part of the difference, the study is not able to show how much.

If it does explain part of the difference, those extra deaths were caused by COVID, not by the Pfizer vaccine. Both vaccines were protective, and one may have protected people a bit more. Without an unvaccinated comparison group, the study can't tell Pfizer causing harm apart from Moderna offering more benefit. The figure below shows how a death caused by COVID can be recorded as a "non-COVID" death and end up looking like harm from the vaccine.

3. Claiming the Pfizer vaccine led to excess deaths requires two assumptions, neither of which holds up.

One widely shared post took the study's Florida results and applied them to the entire U.S., arriving at hundreds of thousands of "excess deaths from Pfizer alone." The post gave two versions of the math. One took the 0.87% annual U.S. death rate, applied it to the roughly 150 million Americans who received Pfizer, and applied the 40% difference on top of that (522,000 deaths). The other multiplied the study's 221 extra deaths per 100,000 by the same 150 million (331,500 deaths). That claim needs two things to be true.

First, the vaccine has to have caused the deaths. Deaths count as excess only if the relationship is causal, which means no confounding or misclassification. It also implies that Moderna is a zero-risk baseline, which a comparison between two vaccines can't show. People die at some rate no matter which vaccine they received. Florida recorded about 261,000 deaths in 2021 and 239,000 in 2022, and, even among Moderna recipients, about 562 in 100,000 died within a year.

Second, scaling up the excess deaths claim nationally requires that the Florida study population resemble the national population. More importantly, the 40% difference came from a matched group that doesn't represent Florida, let alone the country. The matched group made up only 17.4% of the total eligible adults in the study (finding an exact match on that many characteristics leaves many people out).

For example, those who were matched had lower mortality than the full group of eligible adults and skewed more white (77% in the matched group compared with 63% among all eligible adults). It's almost like taking the average height of a college basketball team and multiplying it across all college-aged adults in the U.S.

After reviewing the study, here's where we stand

This is one study, and one study can't settle a question like this on its own. With a large enough study, almost any tiny difference between two groups will look statistically solid. It's like flipping a coin on a slightly tilted table two million times. You'll measure the tilt precisely, and the results will still wrongly suggest the coin is unfair. The VA studies, comparisons of vaccinated and unvaccinated people, and randomized trials each add a different piece, and this study's design is too limited to outweigh them or to support a claim as big as "excess deaths from Pfizer alone."

That being said, we can't say whether the two vaccines differ in some small real way, or how much of the difference comes from COVID protection versus underlying and unmeasured differences between the groups. Anyone claiming certainty in either direction is going further than the data.

Next time you see a claim like this in the media, ask yourself these questions. Start with the comparison group(s). This study compared two vaccines to each other, so it can't say what either vaccine did on its own. Then ask how many people are behind an "X% greater risk," because it can be a small number.

Check whether the comparison groups were similar to begin with, since differences in health can look like differences in a vaccine (look for an apples-to-apples comparison!). Finally, explore what the other studies say, because one result is rarely enough to make a solid conclusion about cause and effect.

Publication details

Retsef Levi et al., Twelve-month all-cause mortality after initial COVID-19 vaccination with Pfizer-BioNTech or mRNA-1273 among adults living in Florida: Statewide cohort study, Global Epidemiology (2026). DOI: 10.1016/j.gloepi.2026.100296

Journal information: British Medical Journal (BMJ)

Who's behind this story?

Gaby Clark

Gaby Clark

MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →

Andrew Zinin

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: Measles elimination at risk—and what a Florida study shows about Pfizer's COVID vaccine (2026, November 13) retrieved 13 November 2026 from https://medicalxpress.com/news/2026-11-measles-florida-pfizer-covid-vaccine.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com